Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in atherosclerosis imaging: electron beam tomography.

H S Hecht1

  • 1Department of Preventive Cardiology and Electron Beam Tomography, Heart & Vascular Institute, 111 Madison Avenue, Morristown, NJ 07960, USA. hhecht@aol.com

Current Atherosclerosis Reports
|August 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes.

Circulation·2001
Same author

Impact of plaque imaging by electron beam tomography on the treatment of dyslipidemias.

The American journal of cardiology·2001
Same author

Lipid disorders and plaque imaging.

The American journal of cardiology·2001
Same author

Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.

The American journal of cardiology·2001
Same author

Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.

Journal of the American College of Cardiology·2001
Same author

Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.

The American journal of cardiology·2001
Same journal

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype.

Current atherosclerosis reports·2026
Same journal

Targeting LDL Across the Whole Spectrum of Chronic Kidney Disease: From Pathophysiology to Novel Treatments.

Current atherosclerosis reports·2026
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
See all related articles

Electron beam tomography (EBT) and electron beam angiography (EBA) offer powerful insights into coronary artery disease. These advanced imaging techniques improve risk assessment, identify treatable disorders, and guide therapy, enhancing patient outcomes.

Area of Science:

  • Cardiovascular imaging
  • Radiology
  • Preventive cardiology

Background:

  • Coronary artery calcium scoring demonstrates significant prognostic power beyond traditional risk factors.
  • Emerging data highlight the expanded applications of electron beam tomography (EBT) and electron beam angiography (EBA).

Purpose of the Study:

  • To review the expanded applicability and clinical utility of EBT and EBA in cardiovascular risk assessment and management.
  • To emphasize the role of EBT/EBA in identifying metabolic disorders and assessing treatment efficacy.

Main Methods:

  • Review of recent data and clinical applications of EBT and EBA.
  • Analysis of the prognostic value of coronary artery calcium scoring.
  • Evaluation of EBA for noninvasive visualization of coronary arteries and bypass grafts.

Related Experiment Videos

Main Results:

  • EBT identifies treatable metabolic disorders contributing to plaque formation and aids in selecting stress test candidates.
  • Changes in calcium scores can assess lipid therapy efficacy and serve as surrogate markers in drug studies.
  • EBA provides effective, noninvasive visualization of native coronary arteries and bypass grafts.

Conclusions:

  • EBT and EBA are increasingly vital tools for cardiovascular risk stratification and management.
  • These imaging modalities enhance the understanding and treatment of coronary artery disease.
  • Coronary artery calcium scoring is poised for greater integration into clinical guidelines.